COVID-19 vaccines now available for children with certain medical conditions aged 6 months to 4 years, in line with the advice of experts
For most children COVID-19 is mild, but infants and young children with certain conditions can become very unwell – they are over seven times more likely to be admitted to intensive care.
Vaccination will help to protect your child from getting seriously ill from COVID-19. Over one million children aged 6 months to 4 years in the US have already received at least one dose of a COVID-19 vaccine with no new or unexpected concerns. The most common side effects reported were mild and similar to those seen with other vaccines given in this age group, such as irritability or crying, sleepiness and fever.
The dose for each vaccination is smaller than the dose given to those aged over 5 years old. To boost their immunity and provide longer term protection, your child will be offered two vaccinations at least 8 weeks apart.
Parents of eligible children aged between 6 months and 4 years old will be invited to book a vaccination appointment by NHS services, for example through their GP Practice.
Where can my child get vaccinated?
COVID-19 vaccinations for children aged 6 months to 4 years are given at the Elizabeth Garrett Anderson Wing, University College Hospital, 25 Grafton Way, WC1E 6DB
The nearest tube stations are Warren Street (Northern / Victoria Lines) and Euston Square (Circle / Hammersmith & City / Metropolitan Lines).
Details of where to find the clinic will be sent to you by email confirmation when you book an appointment.
Frequently Asked Questions
Can my child (aged 6 months to 4 years) receive COVID-19 vaccinations?
If your child is not at increased risk of getting seriously ill with COVID-19, they are not eligible for these vaccinations.
Which vaccine will eligible children (aged 6 months to 4 years) be offered?
In line with JCVI advice, they will be offered two 3-microgram doses of the Comirnaty® vaccine, which is a smaller dose compared to older children and adults.
Why is it important that my child (aged 6 months to 4 years) is vaccinated?
How can I arrange vaccination appointments for my child (aged 6 months to 4 years)?
It is not possible to book appointments for children aged 6 months to 4 years through the National Booking Service, and children in this age group cannot be vaccinated at a walk-in vaccination site.
Local NHS services will invite you to book vaccination appointments for eligible children aged between 6 months and 4 years old. If your child is eligible, please wait to be contacted.
If you have not been contacted by the end of July 2023, and you think your child is eligible, please discuss this with your child’s hospital specialist or GP practice.
My child (aged 6 months to 4 years) has recently had COVID-19. Can they still receive their vaccinations?
If your child has COVID-19, or you think they might, please wait until they’ve recovered before getting them vaccinated. You should also wait if your child has a fever or seems particularly unwell with any illness. If they have recently recovered from an illness, there is no need to delay vaccination.
My child is at increased risk from COVID-19, but they have recently turned 5. Can they still get their vaccine?
If your child is at increased risk and turned 5 years old on or after 1 June 2023, they will be invited by local NHS services to receive the COVID-19 vaccine if they have not had any doses
If your child is at increased risk and turned 5 years old before 1 June 2023, or if they have already had a dose, in most cases, they will have to wait until the autumn to get their next dose.
Why is my child only being offered the vaccine now?
The NHS offers the COVID-19 vaccine in line with Government decisions which are taken following the advice of expert scientists on the Joint Committee on Vaccination and Immunisation (JCVI). The Medicines and Healthcare products Regulatory Agency (MHRA) first approved the Pfizer BioNTech COVID-19 vaccine for children aged 6 months to 4 years in December 2022, concluding it met their standards of safety, quality and effectiveness.
Following its approval, JCVI advised a UK rollout to vulnerable children in clinical risk groups aged 6 months to 4 years. The committee considered data from the US rollout, where over one million doses of the vaccine have been given to children of the same age.